Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary abciximab infusion and aspiration thrombectomy in anterior STEMI undergoing primary PCI
2009-013425-42Phase 4Completed
- Sponsor
- Atrium Medical Corporation
- Start
- Jun 2009
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of abciximab and bivalirudin in myocardial infarction (MI) (4 arms), sponsored by Atrium Medical Corporation. Started Jun 2009; status: completed.
02
Drugs
abciximabbivalirudin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-013425-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013425-42.